HCC Treatment: Sorafenib + TACE

preview_player
Показать описание
Ghassan K. Abou-Alfa, MD, and Masatoshi Kudo, MD, PhD, describe the clinical trial data surrounding the application of sorafenib to transcatheter arterial chemoembolization therapy in patients with hepatocellular carcinoma.
Рекомендации по теме